2ND-LINE DRUG-THERAPY FOR RHEUMATOID-ARTHRITIS

被引：0
|
作者：
CASH, JM
KLIPPEL, JH
机构：
[1] NIAMS, ARTHRITIS & RHEUMATISM BRANCH, BETHESDA, MD 20892 USA
[2] CLEVELAND CLIN FDN, DEPT RHEUMAT & IMMUNOL DIS, CLEVELAND, OH 44195 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1994年 / 330卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1368 / 1375
页数：8
相关论文
共 50 条
  • [1] COMBINATION 2ND-LINE THERAPY FOR RHEUMATOID-ARTHRITIS
    WILLIAMS, HJ
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (07): : 603 - 604
  • [2] THE EFFECT OF ORDER OF 2ND-LINE DRUG-THERAPY ON THE DEVELOPMENT OF SIDE-EFFECTS IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA)
    STEVEN, MM
    HUNTER, JA
    MURDOCH, RM
    MCLAREN, A
    CAPELL, HA
    ANNALS OF THE RHEUMATIC DISEASES, 1981, 40 (02) : 204 - 205
  • [3] 2ND-LINE AGENTS FOR RHEUMATOID-ARTHRITIS
    SCHARF, SL
    CHRISTOPHIDIS, N
    MEDICAL JOURNAL OF AUSTRALIA, 1995, 163 (04) : 215 - 218
  • [4] LONG-TERM 2ND-LINE THERAPY IN RHEUMATOID-ARTHRITIS
    BIRD, HA
    CLINICAL RHEUMATOLOGY, 1985, 4 (02) : 121 - 123
  • [5] SELECTION OF SUITABLE PATIENTS FOR 2ND-LINE THERAPY IN RHEUMATOID-ARTHRITIS
    PULLAR, T
    CAPELL, HA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1986, 25 (03): : 276 - 281
  • [6] PRODUCTION OF INTERLEUKIN-6 BY MONOCYTES ISOLATED FROM RHEUMATOID-ARTHRITIS PATIENTS RECEIVING 2ND-LINE DRUG-THERAPY
    CRILLY, A
    MADHOK, R
    WATSON, J
    CAPELL, HA
    STURROCK, RD
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (09): : 821 - 825
  • [7] DRUG-THERAPY AND RHEUMATOID-ARTHRITIS
    CAPELL, HA
    PULLAR, T
    SCOTTISH MEDICAL JOURNAL, 1985, 30 (03) : 137 - 138
  • [8] DRUG-THERAPY FOR RHEUMATOID-ARTHRITIS
    HATHAWAY, DE
    MINNESOTA MEDICINE, 1985, 68 (08) : 593 - 594
  • [9] DOES 2ND-LINE THERAPY AFFECT THE RADIOLOGICAL PROGRESSION OF RHEUMATOID-ARTHRITIS
    PULLAR, T
    HUNTER, JA
    CAPELL, HA
    ANNALS OF THE RHEUMATIC DISEASES, 1984, 43 (01) : 18 - 23
  • [10] DRUG-THERAPY IN RHEUMATOID-ARTHRITIS
    GIBSON, T
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (13): : 856 - 856
12345